Latest Breaking News On - Astra alexion - Page 1 : comparemela.com
FTSE 100 Live: Blue-chips edge lower while recruiters take a fall
proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.
Astra Strikes $1 Billion Gene Therapy Deal With Pfizer
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
Dive Brief:
AstraZeneca said the Federal Trade Commission has authorized its $39 billion acquisition of rare disease drug developer Alexion, following green lights from regulators in Canada, Brazil and Russia. The U.K. company now expects to be able to complete the deal in the third quarter of 2021, pending approvals in some remaining jurisdictions.
The deal, the largest announced in 2020, aims to beef up AstraZeneca s portfolio by adding Alexion s marketed drugs for orphan blood conditions and enzyme deficiencies. It continues the big pharma s evolution away from primary care drugs and into specialty offerings.
The FTC s decision may be seen as good news for biopharma dealmakers, since the regulator has signaled it will be looking more closely at acquisitions out of concern they may be thwarting the research and development of new drugs. In 2019, the regulator held up one acquisition for months and mandated a product divestment in another before agreeing to approve the deals.